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Abstract
An important part of the radiotherapy process is the calculation of radiation dose
deposition for individual patients. Accurate dose calculation provides a foundation
for accurate dose prescription and reporting in radiation therapy. Several classes
of radiation dose calculation algorithms exist. Some commonly used superposition-
convolution algorithms are Collapsed Cone Convolution (CCC) (Philips Radiation
Oncology Systems, Fitchburg, WI ) and Anisotropic Analytical Algorithm (AAA)
(Varian Medical Systems, Palo Alto, CA, USA). Recently, Varian has introduced
a new algorithm, Acuros XB, which solves the Linear Boltzmann Transport Equa-
tion (LBTE). This study assesses the accuracy of dose calculations performed with
Acuros.
In this study, a Monte Carlo model was created using the EGSnrc family of
Monte Carlo code, in order to run Monte Carlo simulations. A Monte Carlo si-
mulation involves simulating particle transport directly and is considered to be the
gold standard in radiotherapy dose calculations. The Monte Carlo model is used to
assess the accuracy of Acuros XB.
In simple slab geometry, Acuros XB outperforms AAA when compared to Monte
Carlo calculations and to measurements. Acuros XB and AAA show a difference of
-0.06 ± 0.13% and +0.6 ± 0.18% respectively, compared to measured doses distal
to lung slabs of various thicknesses.
Tests described in TecDoc 1583 [Vatnitsky and International Atomic Energy
Agency, 2008] were used to validate Acuros and AAA calculations on a simple
anthropomorphic phantom. Averaged over all TecDoc 1583 test cases and measure-
ment points, AAA calculated dose 0.4 ± 0.4% higher than measured, while Acuros
calculated dose 0.2 ± 0.2% lower than measured.
Calculations were made with Acuros, AAA and CCC for plans with small fields
on Computed Tomography (CT) image sets of SBRT patients. The calculations
were compared with Monte Carlo calculated dose. Acuros showed marginally better
agreement with Monte Carlo than the other algorithms, for the patient plans and
datasets used in this study. For a slice through the target volume of each plan,
Acuros, AAA and CCC had a 98.0%, 97.8% and 96.7% gamma metric pass rate
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1. INTRODUCTION
The lifetime risk of a person developing cancer is approximately 40% [Lag et al.,
1975]. Radiotherapy is an important asset in the management and treatment of
many types of cancer; it is utilised in about 50% of all cancer treatments [Baskar
et al., 2012]. Radiotherapy is the delivery of one or more beams of radiation to the
site of the disease, with the intent of reducing or destroying the disease volume.
Radiation destroys cancer cells directly via the interaction of ionising radiation with
molecules in DNA, or indirectly by the creation of free radicals, causing DNA damage
through subsequent chemical processes. Damage to normal tissue outside of the
disease volume is minimised through the careful selection of radiation field shape
and size, beam energy, beam angle and attenuators such as a compensator or multi-
leaf collimator.
Damage to tissue correlates with radiation dose received by that tissue. Dose is
defined as the energy absorbed per unit mass in a medium,
D = Eabs/m. (1.1)
Dose has the units of Gray (Gy), where 1 Gy = 1 J/kg. In radiation therapy
photon beams, dose is deposited in a two step process. Photons give energy to
charged particles in a medium through the photoelectric effect, Compton scatter or
pair production. For photons with energies that are typically used in megavoltage
radiation therapy, Compton scatter is by far the most common interaction. The
incident energy that is given to charged particles by photons entering the patient is
called KERMA (Kinetic Energy Released per unit Mass). The resulting energetic
charged particles, primarily electrons, deposit energy through Coulomb interactions.
Under electronic equilibrium, where the number of electrons entering a region is the
same as the number leaving, the dose is related simply to the KERMA through the
equation
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D = K(1− g), (1.2)
where K is the kerma and g is the fraction of energy lost due to bremsstrahlung
production. When electronic equilibrium does not exist, this simple relationship
does not apply. Regions where electronic equilibrium does not exist could be in
small radiation beams, at the interface between different tissues and in low-density
tissue such as lung.
A radiotherapy treatment is a multi-step process. After diagnosis and staging, a
planning CT scan is taken and the radiation oncologist delineates the gross target
volume (GTV). An expansion of the GTV for sub-clinical spread results in the
clinical target volume (CTV). An expansion of the CTV to include geometric and
setup uncertainties results in the planning target volume (PTV). A dose prescription
is given to PTV by the radiation oncologist, with dose limits for organs at risk
(OAR). A plan is then developed for the treatment. The treatment plan describes
the arrangement and weighting of all radiation beams to be delivered to the patient.
Dose calculation is performed in order to assess the suitability of the treatment and
any associated risks, and is reviewed by the radiation oncologist before treatment
commences. Treatment is delivered in multiple fractions, over a time period from a
few days up to 6-8 weeks. Each treatment delivery is guided by planar or volumetric
image matching to ensure that each fraction is delivered as planned.
Dose calculation is a vital part of the radiotherapy treatment process. Van Dyk
[1999] summarises this by noting, ‘the dose calculation algorithm is the most unique,
critical, and complex piece of software in a computerized planning system’. Histo-
rically, dose calculation was performed with a manual calculation based on simple
geometry or patient contours. As computer hardware and technology advanced,
dose calculation shifted to implementation by algorithms run on computers.
An overall accuracy of better than 5% in all stages of treatment delivery is gene-
rally desired with achievable accuracy expected to increase as technology advances
[Papanikolaou et al., 2004]. Each individual step in the treatment process, including
dose calculation, should contribute the smallest possible uncertainty. Increasing the
accuracy of dose calculation will result in a few key improvements:
1. Lower uncertainties in clinical trials - fewer patients are required for the same
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statistical significance achieved.
2. The therapeutic ratio can be increased by allowing dose escalation, such as in
hypofractionated or stereotactic treatment regimes.
Boyer and Schultheiss [1988] calculated that the cure rate of early stage patients
increases by 2% for a 1% improvement in dose accuracy. Since optimisation techni-
ques rely heavily on dose calculation, optimisers can be improved through better
dose calculation algorithms, hence increasing the therapeutic ratio.
The introduction of a new dose calculation algorithm for clinical use requires
careful validation to ensure that the calculated dose matches actual dose under a
variety of conditions. The aim of this thesis is to investigate the accuracy of a new
type of dose calculation algorithm, Acuros XB, under various conditions, including
small fields with heterogeneities.
Chapter 2 reviews dose calculation methods including some of the limitations of
current methods. Chapter 2 introduces Acuros XB and presents a review of work
already undertaken in the literature to validate its use clinically.
A detailed discussion of Monte Carlo dose calculation is given in Chapter 3,
including a review of the codes used in this study and a discussion of the variance
reduction techniques used to decrease calculation times. Chapter 3 also details the
process of modelling a linear accelerator in BEAMnrc for dose calculation purposes.
Chapter 4 provides a detailed discussion of the commercial dose calculation algo-
rithms that have been compared to Acuros XB. Chapter 4 also describes the process
of optimising the beam model for AAA and Acuros XB as well as simple verifications
of the beam model.
The accuracy of Acuros XB and the other commercial dose calculation algorithms
under various conditions is examined in Chapter 5. The calculations made using
these algorithms are compared to Monte Carlo calculations and to measurements.
Chapter 6 presents a discussion of the work undertaken in this thesis.

2. LITERATURE REVIEW
Radiation dose calculation can be performed with a simple equation using measured
beam data. In a homogeneous phantom, the dose D to a point at depth d, and at
an off-axis position x, is calculated through the equation [Gibbons et al., 2014]






where D′0 specifies the output of the machine under reference conditions, MU
(Monitor Units) specifies the output of the machine during treatment, Sc(rc) and
Sp(rd0) are the collimator and phantom scatter factors, PDDN is the percentage
depth dose curve, WF is the wedge factor, TF is the tray factor, OAR is the off-
axis ratio at position x and the last term is a correction for the source-to-surface
distance (SSD) being different from that of the calibration (SSD0).
The collimator and phantom scatter terms describe the change in scatter con-
ditions due to changing the field size from the reference field size. The Percentage
Depth Dose (PDD) curve shows how dose varies with depth for a particular machine
and field size. The wedge factor and tray factor account for the reduction of dose
when a wedged field or attenuator are used. The off-axis-ratio describes the shape
of the radiation field off-axis at depth d and position x.
This method of dose calculation is used as an approximation or verification of
other calculation algorithms. For clinical assessment of dose, computational algo-
rithms calculate dose using Computed Tomography (CT) images taken of a patient.
2.1 Heterogeneities
Heterogeneities in the context of radiotherapy dose calculations are materials in a
patient or phantom that have significantly different radiological properties to water,
such as lung or bone. Heterogeneities in patient geometry can be a source of large
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error in dose calculations. Heterogeneities with relatively high or low densities may
be handled incorrectly by many simple algorithms.
Low density materials in radiotherapy beams present a challenge for dose calcu-
lation methods. In regions distal to a low density material, dose increases relative to
the case with no heterogeneities due to a decrease in photon attenuation in the low
density material. Proximal to the low density interface (i.e a water-air interface), a
decrease in dose occurs due to the loss of backscatter relative to water-only calcula-
tions. In low density materials the increase in lateral scatter of electrons increases
electronic disequilibrium, complicating the dose calculation near the interface. This
effect is exacerbated with small fields and high energy beams. For a dose calculation
algorithm that does not accurately take into account this effect, an under-dosing of
tissue proximal to the low density material relative to reported dose will occur [Klein
et al., 1993].
Methods to account for inhomogeneities are generally either correction-based
(also called semi empirical) or model-based. The first calculates dose by assuming
the patient is water-like and applies an inhomogeneity correction factor, typically
a function ICF (x, y, z). The latter calculates dose from first principles without
requiring a calculation in water.
One of the simplest 1D correction methods uses effective attenuation. This
method gives the correction function [Papanikolaou et al., 2004] as
ICF = eµ
′(d−d′), (2.2)
where d′ is the equivalent water depth, calculated by summing the depths above
the calculation point scaled by the density of the material above it. This does not
take into account any scatter variation introduced by different materials. A more
accurate 1D calculation method which corrects for some scatter in one dimension is
the Ratio of Tissue Air Ratios (RTAR). The Tissue to Air Ratio is defined as the
ratio of dose at the isocentre at a depth d in water to the dose at the isocentre in





where d′ is the equivalent water depth as above. This correction method doesn’t
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take into account the position of the inhomogeneity relative to the correction point.
Methods to enhance the accuracy of the RTAR method include the Power Law




The ‘gold standard’of radiotherapy dose calculation algorithms is the Monte Carlo
(MC) method. Monte Carlo methods calculate dose by simulating a large number of
particle interactions directly in a medium. Interactions are probabilistic and based
on pre-calculated interaction cross-sections for Compton scatter, photoelectric, pair
production, etc. By simulating a larger number of particles, the dose calculated by
Monte Carlo methods approaches the actual absorbed dose. Increasing the number
of particles in the calculation decreases the statistical uncertainty in the final dose.
The main disadvantage of Monte Carlo methods is the speed of calculation; simu-
lating such a large number of particles can be extremely time consuming. Methods
exist to speed up Monte Carlo calculations at the cost of some loss of accuracy but
typically in clinical situations, faster algorithms are used.
2.2.2 Superposition-convolution
Superposition-convolution algorithms are commonly used in modern radiotherapy
treatment planning systems. Here the dose calculation is split into the calculation
of the Total Energy Released per unit Mass (TERMA) and the scattered dose from
the multiple photon interactions and electron transport. The TERMA is the total
energy released in interactions of the incident photons with the material. TERMA
differs from KERMA in that KERMA involves only the kinetic energy of charged
particles in the medium due to interactions of the incident photons. Superposition-
convolution algorithms make use of dose kernels which are pre-calculated data that
describe scatter in a medium at specific particle energies. Dose kernels are typically
calculated by Monte Carlo methods. Dose at a point in the medium is a result of
integrating the product of TERMA and the contribution from the dose kernel over
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the volume of the medium,
D(x, y, z) =
∫ ∫ ∫
T (x′, y′, z′)K(x′, y′, z′;x, y, z)dx′dy′dz′ (2.4)
where T is the TERMA and K is the contribution from the dose kernel origina-
ting at (x′, y′, z′).
Corrections for inhomogeneity are made by scaling both the TERMA and the
dose kernel by the density of the material. Implementations of superposition-
convolution algorithms differ in their dose kernels, handling of heterogeneities and
any approximations or simplifications used. Examples of different algorithms based
on superposition-convolution are Varian’s Anisotropic Analytical Algorithm (AAA)
and Philip’s Collapsed Cone Convolution Superposition algorithm (CCC). Many
studies have examined the validity of both AAA and CCC in homogeneous and he-
terogeneous media [Aarup et al., 2009, Bragg and Conway, 2006, Hasenbalg et al.,
2007, Rong et al., 2006].
2.2.3 Acuros XB
Recently, an algorithm called Acuros XB (AXB) [Failla et al., 2010, Vassiliev et al.,
2010] has been introduced to the Eclipse (Varian Medical Systems, Palo Alto, CA,
USA) Treatment Planning System (TPS). AXB solves the Linear Boltzmann Trans-
port Equation (LBTE), a set of equations that describes the macroscopic transport
of ionising radiation. Analytical solutions to the LBTE, especially in radiotherapy,
are generally not known due to the complexity of conditions. Thus, numerical met-
hods are used to solve the LBTE, discretising in space, angle and energy. A more
detailed description of the algorithm is given in Chapter 4.
Fogliata, Nicolini, Clivio, Vanetti, Mancosu and Cozzi [2011] have validated the
implementation of Acuros XB in the Eclipse TPS in water for simple geometries.
The study was carried out using 6 and 15 MV beams and 6 and 10 MV flattening
filter free beams. Comparisons were made between AAA, AXB and measurements.
Agreements for all methods were found to be within 1% for the open beams and 2%
for beams when using mechanical wedges.
Using ion chamber measurements in a homogeneous phantom, Bush et al. [2011]
found agreements better than 1.9 % with AXB for field sizes between 4 x 4 and 30
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x 30 cm2 for 6 and 18 MV beams.
Han et al. [2011] found agreements between Monte Carlo , AXB, AAA and CCC
for PDDs calculated in a homogeneous phantom of within 1.5% for 6 MV and 2.5%
for 18 MV. They found agreements between the lateral dose profiles at various depths
and field sizes for the same algorithms of better than 2% for 6 MV and similar for
18 MV beams.
AXB is claimed to have similar accuracy in heterogeneous mediums as MC met-
hods. Many studies have examined the accuracy of AXB in heterogeneous phantoms,
either real or virtual. Fogliata, Nicolini, Clivio, Vanetti and Cozzi [2011a] looked at
MC and AXB in heterogeneous phantoms for field sizes of 13 x 13 cm2 and 2.8 x 13
cm2 with 6 and 15 MV photon beams, finding differences corresponding to average
gamma agreement (3%, 3 mm) of 100%, 86% and 100% for lung, low-density lung
and bone, respectively. The gamma metric is described in detail in Appendix C.1.
Bush et al. [2011] compared MC calculations to AXB and AAA calculations in a
heterogeneous phantom simulating lung and low-density lung, finding disagreement
between MC and AXB algorithms of better than 2.9% with much larger differences
found between AAA and MC. On a phantom containing an air cavity, agreements
between AXB and Monte Carlo calculations were found to be between 1.5 and 4.5%.
Han et al. [2011] compared the DOSXYZnrc MC program, AXB, AAA and
CCC algorithms in a heterogeneous slab phantom made up of bone, lung and soft
tissue equivalents. They compared depth doses, lateral dose profiles and overall
dose difference with a 3D gamma comparison. AXB was found to have much closer
agreement to MC than AAA and CCC especially at the interface regions between
differing materials. In the heterogeneous phantom, the average difference in depth
dose between the algorithms and Monte Carlo were 1%, 2.9% and 1.8% for AXB,
AAA and CCC respectively. Mißlbeck and Kneschaurek [2012] examined PDDs
and lateral profiles in two simple phantoms: slab and lung. Comparisons were
made between AXB, AAA and the commercial X-ray Voxel Monte Carlo algorithm
(XVMC) (Brainlab, Munich, Germany). The study showed that there was better
agreement between AXB and XVMC than between AAA and XVMC.
Tsuruta et al. [2014] compared PDDs and dose profiles in simple lung equivalent
phantoms using AAA, AXB, XVMC and measurements for field sizes from 2 x
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2 cm2 to 10 x 10 cm2. They found good agreements between AXB, XVMC and
measurements. Dose calculated with AAA was higher than measurements in the
heterogeneous zone near the boundary of the lung equivalent material.
Rana and Rogers [2013a] compared AXB and AAA to measurements made in
solid water with a varying air gap before the measurement point of between 2 - 6
cm and field sizes of 3 x 3, 5 x 5 and 10 x 10 cm. They found better agreement
to measurements with AXB rather than AAA, with the biggest discrepancy found
when measuring the smallest field size with the largest air gap. A repeat of this
setup but with two air gaps found similar results [Rana et al., 2013b] with both
AXB and AAA underestimating dose.
Lloyd and Ansbacher [2013] examined high density implants in a water phantom,
finding that AXB gave better agreements than AAA with Monte Carlo and film
measurements. They also recalculated a clinical prostate plan with a hip prosthesis
present with AAA, AXB and MC, finding similar results: large differences between
AAA and Monte Carlo on the upstream medial surface of the prosthesis.
Ojala et al. [2014] performed a study comparing measurements in an anthropo-
morphic phantom with a unilateral hip implant (a Ti6A14V alloy) to AXB, AAA
and MC model, finding excellent agreement of AXB and MC with measurements.
Dose calculations in small fields can be particularly inaccurate due to the loss
of electronic equilibrium. The effects are heightened in heterogeneous mediums.
Stathakis et al. [2012] examined the accuracy of AXB, CCC and AAA for field sizes
from 1 x 1 cm2 to 10 x 10 cm2 in homogeneous and simple heterogeneous virtual
phantoms. They found better agreement to MC with AXB and CCC than AAA. Kan
et al. [2012] used AAA and Acuros to calculate PDDs in a heterogeneous phantom
containing air cavities and compared them to measurements and MC calculations.
At the air/tissue interfaces AXB overestimated dose by 6% and AAA overestimated
dose by 41%.
Intensity Modulated Radiotherapy (IMRT) and Volumetric Modulated Arc Ther-
apy (VMAT) are methods of radiation delivery that modulate each beam with Mul-
tileaf Collimators (MLCs). As a result, each field is the summation of typically
many smaller fields, presenting a difficulty for dose calculation algorithms. VMAT
differs from IMRT in that there are many more discrete beams in each treatment.
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Han et al. [2012] looked at VMAT and IMRT plans on an anthropomorphic head
and neck phantom, comparing AXB and AAA calculations with measured TLD and
2D film readings. The study found good agreement for both algorithms, with AXB
performing only slightly better.
Han et al. [2013] calculated IMRT/VMAT plans on the Radiological Physics
Centre thorax phantom. The study showed that AAA and AXB (dose to water)
had gamma pass rates (3%, 3 mm) of 94% and 98% when compared to film mea-
surements. The biggest differences between the AXB and AAA calculations were
found at lung/soft tissue interface regions for individual IMRT fields.
Hoffmann et al. [2012] tested various patient plans, including IMRT and VMAT
on a heterogeneous Computerised Imaging Reference System (CIRS) thorax phantom
(CIRS, Norfolk, VA), finding better agreement to measured data with AXB over
AAA. Kan et al. [2012] assessed AXB for use in nasopharyngeal carcinoma by de-
livering plans made to treat nasopharyngeal carcinoma to a rectangular phantom
with air and bone inserts and an anthropomorphic phantom containing heterogene-
ous media. Measurements were made with thermoluminescent dosimeters (TLDs)
and Gafchromic EBT3 film. Based on the film results, they found that compared
to AAA, AXB gave only slightly better agreement with measurements in and near
heterogeneous media.
Tsuruta et al. [2014] compared 26 lung Stereotactic Body Radiation Therapy
(SBRT) plans calculated with XVMC, AAA and AXB. AXB calculation resulted
in a slightly lower maximum dose in the ITV and (PTV) but with a similar dose
distribution on isocentre planes in axial and sagittal views. Ojala et al. [2014] found
good agreement in a VMAT plan using AXB and MC calculations in a CT dataset
containing a high density implant. AAA was found to have larger discrepancies
with MC, especially at the interface between soft tissue and implant. Acuros was
successfully able to model the increased backscatter from the high-Z material.
Due to the complex structure of the mammary gland and the presence of lung
tissue, inhomogeneity corrections for the treatment of breast cancers can be a diffi-
cult problem. Fogliata, Nicolini, Clivio, Vanetti and Cozzi [2011b] compared AAA
and AXB, noting that AAA predicted, on average, 1.6% higher dose than AXB in
muscle tissue. Rana and Rogers [2013b] found little difference between AAA and
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AXB calculations in plans made on prostate cancer patient CT datasets, with AAA
predicting slightly higher doses at most points. Kroon et al. [2013] found that, com-
pared to AAA, using AXB resulted in D98% being significantly higher in stereotactic
VMAT lung plans. Liu et al. [2014] found no difference between mean dose in PTVs
of lung SBRT patients between AXB and AAA, however the conformity of the PTV
was lower in AXB than AAA. The difference in PTV conformity between the two
algorithms arises from AAA overestimating dose near the edge of the heterogeneity.
Table 2.1 shows a summary of the literature as discussed above. A significant
amount of verification of Acuros XB has already been performed, however studies












Tab. 2.1: Summary of literature relating to Acuros verification






3 x 3 cm to
40 x 40 cm
AAA Ion chamber 1 % agreement for open beams,
2 % for mechanical wedges.
Bush et al. [2011] Homogeneous, lung,
low-density lung, air,
bone.
4 x 4 cm to
30 x 30 cm
AAA, EG-
Snrc
Ion chamber Acuros agreement to MC within
2% in lung, 2.9% in low-density
lung. AAA showed agreements of
10.2% and 17.5% in lung and low-
density lung.





2.5 x 2.5 cm,
5 x 5 cm,




None AXB, AAA, CCC average PDD
differences to MC were 1.1%,
4.4% and 2.2% respectively.
Fogliata, Nicolini, Cli-





2.8 x 13 cm,
13 x 13 cm
AAA,
VMC++
None AXB & MC gamma greement
(3% 3 mm) was 100%, 86% and
100% for lung, light lung and
bone. AAA & MC gamma
















2.5 x 2.5 cm,




None AAA and XVMC showed diffe-
rences of up to 13% in PDDS in
lung. No differences in DVH in
clinical cases.
Tsuruta et al. [2014] Heterogeneous water
& lung phantom, 26
SBRT lung plans







AXB within 3% of XVMC in
SBRT plans. AAA agreement





a high density vo-
lume, Clinical pro-
state plan with unila-
teral hip prosthesis.









Film AXB performs as well as MC and
better than AAA when high den-






3 x 3, 5 x 5,
10 x 10 cm
AAA Ion chamber AXB showed better agreement
with measurement at all points,
with AAA underestimating dose
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AAA produced larger discrepan-
cies than Acuros compared to
MC.
Stathakis et al. [2012] Homogeneous and he-
terogeneous cases, two
VMAT cases.
1 x 1 cm to




None AXB comparable with MC, with
improved accuracy over AAA and
CCC.
Kan et al. [2012] Rectangular phantom
containing air cavity.
2 x 2 to
5 x 5 cm
AAA, EG-
Snrc
TLD AXB overestimated dose at air/-
tissue interfaces by 6% and AAA
overestimated dose by 41%





AAA TLD, Film AXB slightly better than AAA
(0.1% to 3.6%) vs (0.2% to 4.6%)
compared to TLD measurements
Han et al. [2013] Thorax phantom. VMAT
and IMRT
AAA TLD, Film Differences of up to 8% between
AXB and AAA were found in
lung/soft tissue interface regions.
AXB produced better agreement
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AAA Film, ion cham-
bers, diamond
detector.
Better agreement to measured
with AXB vs AAA.
Fogliata, Nicolini, Cli-
vio, Vanetti and Cozzi
[2011b]
Ten breast patients. Breast
plans
AAA None AAA predicted higher dose than
Acuros in muscle tissue (lobular
breast). Lung doses from AXB
and AAA differed by 0.5 % (free
breathing) to 1.5% (DIBH).





AAA None AAA & Acuros comparable in
prostate cancer VMAT plans
(highest dose difference in PTV
was 0.43%).





AAA None AAA computed dose up to 12.3%
higher in small PTVs than AXb





AAA None No statistical differences were
found for mean PTV dose bet-
ween the two algorithms.
3. MONTE CARLO MODEL
A typical linear accelerator operates with 2 x 1012 electrons per pulse. At a Pulse
Repetition Frequency of 250 Hz, there will be approximately 1 x 1016 electrons
incident on the accelerator target for a typical 2 Gy fraction. Ideal dose calculation
algorithms would simulate every particle and every interaction in order to determine
total energy deposition in a phantom or patient. Clearly, to fully replicate the
physical processes of a linear accelerator an enormous and impractical amount of
computing time is required.
Instead of simulating each and every particle interaction, a statistical approach
is used; simulating a large number of incident particles can approximate linear acce-
lerator output with good accuracy and increasing precision in a reasonable time
period. The statistical approach of simulating real world processes is called the
Monte Carlo method.
Monte Carlo particle transport is carried out through computer code which fol-
lows each particle through many interactions. Each interaction has a certain pro-
bability of occurring. Particle interaction probabilities and interaction results are
determined through energy-dependent cross-sections. These cross-sections are well
known and have been studied extensively. Thus, realistic physical interactions are
simulated in Monte Carlo code.
During each photon step, Monte Carlo code would: [Metcalfe et al., 2007]
1. Calculate the distance the photon moves, based on photon energy and the
attenuation coefficient of the medium through which it is travelling
2. Determine which photon interaction takes place
3. Calculate the new energy and direction of travel for the photon
4. Add any particles which are created during photon interaction.
Various techniques are used to decrease statistical uncertainty for a given treat-
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ment time. These are discussed in Section 3.3.1 below.
3.1 Monte Carlo codes
There are multiple Monte Carlo codes which are commonly used in radiation therapy
simulations: EGSnrc, GEANT4, MCNP and PENELOPE. In this study, EGSnrc is
used.
3.1.1 EGSnrc
EGS (Electron Gamma Shower) consists of code for simulating the transport of
electrons and photons in various geometries with energies ranging from a few keV
to several hundreds of GeV [Kawrakow and Rogers, 2000]. EGSnrc is the code upon
which BEAMnrc and DOSXYZnrc are built.
EGSnrc creates particles from a source, simulates their interactions (which may
or may not produce more particles) and continues this for the initial and subsequent
particles until they leave the geometry, are absorbed, or are until they are culled by
variance reduction techniques.
Photon interactions simulated by EGSnrc include photo-electric absorption, Ray-
leigh scattering, Compton scattering and pair/triplet production.
Electrons undergo a huge number of interactions while slowing down. Most of
these interactions transfer no energy or a small amount of energy to the medium
and so the condensed history technique [Berger, 1963] is used by EGSnrc to achieve
practical computation times. The condensed history technique groups many inte-
ractions into a single step by sampling the change of the particle’s energy, direction
of motion, and position, at the end of the step from appropriate multiple scattering
distributions [Kawrakow and Rogers, 2000].
3.1.2 BEAMnrc
BEAMnrc is a system for radiation simulation using radiotherapy sources. It uses
EGSnrc for radiation transport. BEAMnrc adds various variance reduction techni-
ques such as range rejection, bremsstrahlung splitting, photon forcing and Russian
roulette. It also simplifies defining accelerator geometry by providing specific com-
ponents such as slabs, cones and flattening filter geometries.
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3.1.3 DOSXYZnrc
DOSXYZnrc is a system used for 3-dimensional absorbed dose calculations [Walters
et al., 2005]. It allows the user to define a 3-D geometry consisting of voxels of
varying materials/densities in which absorbed dose is calculated. DOSXYZnrc uses
EGSnrc for photon and electron transport in the volume and can use sources such
as parallel or diverging beams, or BEAMnrc simulation results as input.
3.2 Modelling a Linear Accelerator
A Varian (Varian Medical Systems, Palo Alto, CA, USA) Trilogy Linear Accelera-
tor was modelled in BEAMnrc for this study. The process of modelling a linear
accelerator involves two main steps; defining the geometry of each component, and
modifying the incident electron fluence to match measured beam data [Rogers et al.,
2009]. These two steps are described in more detail below.
3.2.1 Components
Linear accelerator components were modelled by using technical drawings from the
manufacturer which specify the dimensions and materials of each component. BE-
AMnrc has a number of components which help to construct linear accelerator mo-
dels for Monte Carlo calculations. Figure 3.1 shows the geometry of the accelerator
used in this study for Monte Carlo calculations. The physical density assigned to
each component in BEAMnrc greatly affects calculated dose. Sheikh-Bagheri and
Rogers [2002] suggest that the density of the flattening filter and primary collimator
should be known to within ±0.1 g cm-3 in order to properly match off-axis ratios.
BEAMnrc has a graphical user interface (GUI) simplifying the process of defining
components.
Target
The target was modelled as two thin slabs. The material used for the first slab was
tungsten (W700ICRU) and the second slab was a thin slab of copper (CU700ICRU).
The slabs can be considered infinite in length compared to the radius of the incident
electron beam.
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Fig. 3.1: The geometry of the linear accelerator used for Monte Carlo based dose cal-
culations. Note that only one jaw is visible as the figure is viewed in the XY
plane.
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Primary collimator
The primary collimator was modelled with the CONS3R component which is a stack
of truncated cones coded as three regions [Rogers et al., 2009]. The radii of the top
and bottom part of the primary collimator were selected to give an opening angle
of 13.5 degrees, based on manufacturer drawings. Inside the primary collimator is
considered a vacuum region.
Flattening filter
The flattening filter was modelled with the FLATFILT component. The FLATFILT
component enabled the entry of the flattening filter geometry as layers of cones with
several materials used on each layer. The flattening filter consisted of 20 layers of
cones with copper selected as the material.
A linear accelerator flattening filter is designed so that the linear accelerator
produces a beam that is flat as possible at 10 cm depth in water. The density of
the flattening filter affects the attenuation of the beam across the flattening filter
and will change the resulting intensity profile and energy distribution of the beam
exiting the flattening filter. Sheikh-Bagheri and Rogers [2002] found that increasing
the density of flattening filter material by 1 g cm-3 will increase off-axis ratios by
6%. This effect was found during the modelling of the accelerator used in this study
and an example of its magnitude is shown in Figure 3.2. The flattening filter density
used in this study was 9.5 g cm-3.
3.2.2 Mirror and MU Chamber
The mirror was initially modelled with the BEAMnrc MIRROR component, however
the dosimetric impact of including the mirror was small and so the mirror was
removed in subsequent dose calculations.
The linear accelerator’s MU chamber was modelled with slabs based on Varian
specification. Since this thesis is not concerned with absolute dosimetry or calcu-
lating output factors, and as the dose difference calculated with and without this
component was found to be small, the MU chamber was not used in subsequent dose
calculations.
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FF  cm g 9.9 Density -3 
FF Density 8 .9 g cm -3  - - -
Fig. 3.2: The effect of flattening filter density on off-axis ratios. The solid profile shows the
increase in off-axis-ratios for a 40 x 40 cm2 field when a flattening filter density
of 9.9 g cm-3 is used instead of the default density of 8.9 g cm-3
The close match of the final Monte Carlo model with measured data is further
justification for the removal of these two components.
Secondary collimator (X and Y Jaws)
The X and Y jaws were modelled with the BEAMnrc JAWS component. The
thickness in the Z direction was set to 7.7 cm and opening widths were based on the
field size for which the calculation was being made. The material used was tungsten
(W700ICRU).
3.2.3 Incident electron beam
BEAMnrc allows several different sources of radiation to be used. In this study an
elliptical electron beam with Gaussian distributions in X and Y is used. The Full-
Width Half-Maximum (FWHM) in both the X and Y directions can be adjusted to
change the size of the source. The angular spread (UINC, VINC and WINC) can
be adjusted, however makes little difference to dose calculations [Sheikh-Bagheri
and Rogers, 2002]. The FWHM of the electron beam has little effect on calculated













Fig. 3.3: The effect of the size of the incident electron beam on off-axis ratios. The blue,
dashed profile shows the increase in off-axis-ratios for a 40 x 40 cm2 field when
a beam size of 0.5 mm is used. The black, solid profile shows the off-axis-ratios
for an electron beam size of 2.5 mm. Both calculations used a flattening filter
density of 9.5 g cm-3
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PDDs for a 10 x 10 cm2 field, however modifying the FWHM by a few tenths of
a mm will result in off-axis-ratio changes of several percent [Sheikh-Bagheri and
Rogers, 2002]. Increasing the FWHM of the electron beam results in a relatively
more intense photon beam on the central axis [Sheikh-Bagheri and Rogers, 2002].
An example of the effect of the FWHM on off-axis ratios is shown in Figure 3.3.
The energy and FWHM of the incident electron beam were chosen using the
method recommended by Sheikh-Bagheri and Rogers [2002]; the energy of the elec-
tron beam was set by matching a PDD for a 10 x 10 cm2 field to measured data.
The FWHM of the electron beam was set by matching off-axis-ratios of a 40 x 40
cm2 field to measured data. As the flattening filter density was not known, and can
vary between machines, the density of the flattening filter was another variable mo-
dified to match both off-axis-ratios and PDDs of the linear accelerator used in this
study. Thus, the modelling was an iterative process involving modifying electron
beam energy, electron beam size and density of the flattening filter.
In this study, the incident electron beam is treated as mono-energetic with an
energy of 5.95 MeV. The FWHM of the electron beam found to best match measured
data was 0.1 x 0.1 cm.
3.3 EGSnrc/BEAMnrc/DOSXYZnrc
3.3.1 Variance reduction techniques
BEAMnrc employs several variance reduction techniques which work to improve the
variance of a simulation for a given simulation time or decrease the simulation time
for a given variance.
Range rejection
The range rejection method calculates the range of a charged particle and terminates
its history (depositing all of its energy at that point) if it cannot leave the current
region with energy >ECUTRR. ECUTRR is defined as the range rejection cutoff
energy and can be different in each region. To limit the loss of bremsstrahlung
photons due to removing electrons that cannot escape the region, an ESAVE value
(the maximum energy at which range rejection is considered) of 2 MeV is used
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globally. This ensures that range rejection is not considered for electrons with energy
greater than 2 MeV. Range rejection is turned off in the target by setting ESAVE
to 20 MeV for the tungsten slab representing the target.
Bremsstrahlung splitting
Bremsstrahlung splitting is a variance reduction technique where the creation of
bremsstrahlung photons is modified so that for each electron interaction, an arbitrary
number of bremsstrahlung photons is produced with their individual weights reduced
[Kawrakow and Rogers, 2000]. The energy of the initial electron is reduced by
only one of the photon’s energies in order to conserve energy loss straggling effects.
Therefore for this technique, energy is not conserved in each interaction; energy is
conserved on average over many histories [Rogers et al., 2009].
In directional bremsstrahlung splitting (DBS), photons that have been split as
described above are removed using a Russian roulette routine if they are not ai-
med into the field of interest defined by the ‘splitting field’[Kawrakow et al., 2004].
The Russian roulette routine compares a random number to a survival threshold of
1/NBRSPL, where NBRSPL is the splitting number. If the random number is less
than the threshold, the photon is kept and its weight increased; this photon is now
considered a ‘fat’(high weight) photon. Otherwise it is removed.
Compton events involving fat photons (those that are not aimed into the splitting
field) will result in splitting the Compton event NBRSPL times. The resulting
particles are weighted with 1/NBRSPL and Compton scattered photons not directed
into the field of interest, as well as secondary electrons, undergo Russian roulette as
described above.
For non-fat photons about to undergo a Compton event in a gas, the event
proceeds and Russian roulette is run with the resultant Compton scattered photon
if it is not pointed towards the field of interest. If the nonfat photon is not in a gas,
Russian roulette is run with the photon before the event takes place. If the photon
survives, its weight is increased and it becomes a fat photon [Kawrakow et al., 2004].
The result of the above is that only a few fat charged particles reach the phantom
surface and so statistics for contamination electrons are poor. To rectify this, BE-
AMnrc DBS can make use of charged particle splitting whereby electrons crossing
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a splitting plane (usually defined at the bottom of the flattening filter) are split
NBRSPL times, with a subsequent reduction in weight.
Kawrakow et al. [2004] found that DBS increases calculation efficiency by a
factor of 500 versus no Bremsstrahlung splitting schemes and a factor of 20 over
uniform Bremsstrahlung splitting. The optimum DBS splitting number is found to
be 1000 regardless of splitting plane location. Fragoso et al. [2009] found between
a 53-fold to 115-fold improvement in calculation time when DBS with NBRSPL =
100 and electron splitting was used. Mohammed et al. [2016] found an improvement
in calculation time of approximately 1130-fold for DBS vs no DBS.
In this work, DBS is used with a splitting number of 1000 and a splitting field
radius of 15 cm at 100 cm SSD for a 10x10 cm2 field and a radius of 45 cm for a
40x40 cm2 field.
Charged particle splitting is also employed, with the splitting plane at the bottom
of the flattening filter (Z = 12.5 cm). A Russian Roulette plane was placed a few
mm above the splitting plane (Z = 12.3 cm), still within the flattening filter, as
suggested in Rogers et al. [2009]. A rejection plane was used with a Z of 75 cm so
that it is in-air between the last component of the linear accelerator and the scoring
plane.
Photon splitting in DOSXYZnrc
Photon splitting in DOSXYZnrc can be employed to improve the efficiency of photon
beam simulations. In this algorithm, photons of weight w0 entering the DOSXYZnrc
phantom are split nsplit times and assigned a weight of w0/nsplit. Scattered pho-
tons resulting from interactions are culled with a Russian roulette routine whereas
charged particles are kept with a reduced weight [Kawrakow and Walters, 2006]. Ka-
wrakow and Walters [2006] found that a splitting number of 40 increased efficiency
by a factor of 5 or more. In this study, a splitting number of 40 is used.
3.3.2 Phase space files
Standard BEAMnrc calculations will produce a phase space file for each scoring
plane. The phase space file contains data relating to particle position, energy, weight,
interactions, etc. for every particle that crosses the scoring plane [Rogers et al.,
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2009]. For typical accelerator simulations, file sizes range from a few hundred MB to
several GB. The phase space files can be used as input to a DOSXYZnrc calculation.
Alternatively, a BEAMnrc treatment head simulation can be used as input to
DOSXYZnrc calculations. This uses particles sampled from a BEAMnrc simulation
running concurrently with the DOSXYZnrc calculation [Walters et al., 2005]. This
method has the advantage of only one simulation being required to run. Kawra-
kow and Walters [2006] found only a 5-12% efficiency increase when using a phase
space file as input, versus using a treatment head simulation as input, as long as
DOSXYZnrc photon splitting is used.
In this study the BEAMnrc treatment head simulation was used as input for
most DOSXYZnrc calculations.
3.3.3 Other parameters
The boundary crossing algorithm controls the transport of electrons across region
boundaries. The boundary crossing algorithm (BCA) EXACT, which is the default
BCA, was used as opposed to PRESTA-I. This is due to the overestimation of dose
resulting from PRESTA-I [Kim et al., 2012, Walters et al., 2005].
The parameter ECUT helps to reduce calculation time by terminating particles
when their energy falls below a user-defined cut-off value. Rogers et al. [2009] suggest
an electron cut-off energy (ECUT) of 0.7 MeV and photon cut-off energy (PCUT) of
0.01 MeV. Increasing ECUT above 0.511 MeV will result in an increasing uncertainty
of surface dose calculations [Kim et al., 2012]. This uncertainty, however, is within
0.1 mm of the surface and is irrelevant for this work, thus ECUT and PCUT values
were 0.7 and 0.01 MeV, respectively.
3.4 Comparison with measured data
Measured beam profiles and PDDs were compared with Monte Carlo calculated
beam profiles and PDDs. Measured data was collected as discussed in Chapter
4 and was made available by the clinic for use this study. Measured data was
in RFA300 Beam Data format. DOSXYZnrc calculations generated .3ddose files,
which are described in Walters et al. [2005]. A computer program was written in
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MATLAB in order to read measured beam data, as well as DOSXYZnrc output, for
comparisons.
Output from DOSXYZnrc is in terms of Gy/number of incident particles. In
order to compare the output with measured data, the output was normalised. Pro-
files were normalised using an average of three points; the output on the CAX and
the output 2 mm either side of the CAX. PDDs were normalised by the dose at a
depth of 10 cm. Linear interpolation between data points was used if the normalisa-
tion points did not exist. Software was written to perform one-dimensional gamma
analysis between two profiles. The gamma metric is described in Appendix C.1.
Initial model validation was performed by matching a calculated 10 x 10 cm
PDD to a measured PDD. A gamma comparison (tolerance 1%, 1 mm) between the
measured profile and the calculated profile resulted in 100% of points with a gamma
value less than 1.0. The mean γ value was 0.280 and the median γ value was 0.236.
This comparison is shown in Figure 3.4. A 3 x 3 cm PDD is shown in Figure 3.5.
Secondary validation was performed by matching a calculated 40 x 40 cm profile
to a measured profile at 1.5 cm depth. This comparison is shown in Figure 3.6. The
penumbra is sharper in the calculated dose distribution as the voxel size used in the
calculation is smaller than the width of the chamber used for data collection. The
gamma metric is above 2.0 for the umbra region, however the gamma calculation
uses a local difference metric rather than a global; thus the difference in absolute
terms is small and is expected to make little difference on subsequent calculations.
The final Monte Carlo model agrees well with measured data.
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(a) 10 x 10 PDDs










Fig. 3.4: A comparison of a 10 x 10 cm PDD curve calculated with EGS/BEAMnrc
(Energy = 5.95 MeV, FWHM = 0.1 x 0.1 cm), with the corresponding gamma
comparison (1%, 1 mm).
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Fig. 3.5: A comparison of a 3 x 3 cm PDD curve calculated with EGS/BEAMnrc (Energy
= 5.95 MeV, FWHM = 0.1 x 0.1 cm), with the corresponding gamma comparison
(1%, 1 mm).













(a) 40 x 40 profiles









Fig. 3.6: A comparison of a 40 x 40 cm profile (1.5 cm depth) calculated with EGS/BE-
AMnrc (Energy = 5.95 MeV, FWHM = 0.1 x 0.1 cm), with the corresponding
gamma comparison (1%, 1 mm)

4. DOSE CALCULATION MODELS
Dose calculation in external beam radiotherapy has evolved from correction-based
algorithms to more advanced model-based algorithms, such as superposition con-
volution. As part of the commissioning process, linear accelerator beam data is
measured and used to tune the dose calculation algorithm or verify an existing mo-
del. In this thesis, Acuros and AAA models were created and parameters modified
in order to create the best fit with measured data. AAA version 13.7.16 and Acuros




The Wellhofer (Scanditronix-Wellhofer, Schwarzenbruck, Germany) CC13 ionisation
chamber was utilised in many beam data measurements. It has an active volume
of 0.13 cm3. This chamber is small enough to avoid volume averaging effects in
most radiation fields but has a large enough volume to obtain a good signal during
measurements. For field sizes of around 3 x 3 cm2 and lower the chamber begins to
have some limitations.
IBA SFD Stereotactic diode
The IBA (IBA Dosimetry, Schwarzenbruck, Germany) SFD Stereotactic diode was
used for measurements of profiles, PDDs and output factors for small radiation fields.
It was used to verify penumbral dose modelling of all fields. The diode has a sensitive
volume of 0.017 mm3. The diode is unshielded which reduces any perturbation
effects. Diodes typically show an over-response to lower energy radiation and so
may over-estimate the umbra region of larger fields. The advantage of using the
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diode in small fields is that it minimises the volume averaging present with larger
dosimeters.
4.1.2 Measurement process
Most of the beam data required for commissioning Eclipse had already been mea-
sured prior to this project, as it had been used to commission the Pinnacle TPS.
PDDs for field sizes less than 5 x 5 cm2 were measured with the stereotactic
diode. PDDs for field sizes greater than 5 x 5 cm2 were measured with the CC13
chamber and the stereotactic diode; the diode measurements were combined with the
CC13 chamber to provide a higher resolution measurement of the buildup region.
Some PDDs had final depths shallower than the 30 cm required by Eclipse, so a
small extrapolation to 30 cm was used for those PDDs.
Profiles for field sizes less than 5 x 5 cm2 were measured with the stereotactic
diode. Profiles for field sizes greater than and equal to 5 x 5 cm2 were measured with
the CC13 ionisation chamber. A CC13 chamber was used as a reference dosimeter
to remove linear accelerator output variations during measurements. Profiles were
measured at depths 1.5, 5, 10, 20 and 30 cm.
Diagonal profiles for the largest field size (40 x 40 cm2) were not part of the
initial beam data set and so had to be measured. Diagonal profiles were measured
with the CC13 chamber at depths of 1.5, 5, 10, 20 and 30 cm.
Output factors in the existing beam dataset were measured with a 100 cm SSD
and a depth of 10 cm. Eclipse documentation suggests that output factors are
measured isocentrically and so were re-measured with a 95 cm SSD and a depth of
5 cm.
Eclipse beam configuration software requires data in the w2CAD format. Our
installation of OmniPro did not have the ability to export in this format so some
software was written to perform this conversion.
4.2 Collapsed Cone Convolution Superposition
Collapsed Cone Convolution Superposition (CCCs) is used in the Pinnacle TPS
(Philips Radiation Oncology Systems, Fitchburg, WI) which is currently the main
TPS used in this clinic. CCCs is a superposition convolution algorithm. A general
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description of superposition-convolution algorithms is given in Section 2.2.2. Hete-
rogeneity scaling is accounted for by using a radiological distance in the TERMA
calculation and when adding contributions from dose kernels.
The CCC algorithm discretises the dose kernels so that each represents a cone
where all energy is collapsed to the centre of the cone. Thus for a single interaction
point, the energy deposited from the point spread kernel emanates along certain
directions. This greatly reduces computation time, since the number of directions
that energy is scattered from each interaction point is reduced considerably. Scaling
of the kernels due to inhomogeneities is implicitly handled by considering radiological
distances.
The CCCs model utilised in this study had been in clinical use for some time
and had previously been commissioned.
4.3 Anisotropic Analytical Algorithm
AAA is a superposition convolution algorithm. AAA has four sources used for
primary dose deposition: primary source, second source, electron contamination
and photon scatter from wedges.
The primary source is a point source which models the bremsstrahlung photons
created in the target. The beam spectrum after exiting the target is based on BE-
AMnrc calculations. The finite size of the source is modelled with the effective target
spot size parameters (X and Y directions). Adjusting these parameters changes the
size of the penumbra and has a significant effect on the absolute dose level in small
fields [Varian, 2014]. The energy fluence across the field is modelled by a radially
varying intensity profile curve. Beam hardening in the flattening filter is model-
led by attenuating the spectrum with a radially varying amount of flattening filter
material, or for a flattening filter free beam, the energy spectrum for each beamlet
across the beam is adjusted via the mean energy curve, which decreases smoothly
as the radius increases.
The second source models the photons that arise from interactions outside the
target: in the flattening filter, primary collimator and secondary jaws. The source
is a Gaussian plane at the bottom of the flattening filter. Adjusting the second
source parameters, such as the secondary source spot size, mean energy and relative
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intensity, has a large effect outside of the primary beam.
The electron contamination source models dose deposited by contamination elec-
trons in the beam. This dose is deposited mainly in the build-up region of the beam.
Eclipse accounts for phantom scatter and head scatter effects via the dose cal-
culation algorithm and the photon beam source. Collimator Back Scatter Factors
(CBSF) are calculated by Eclipse to account for the remaining change in output fac-
tors not modelled by the algorithm and photon beam source. Physically, they are
supposed to represent the collimator backscatter into the monitor chamber. CBSFs
are calculated from measured output factors via the equation
CBSF (X, Y ) =
OFref





with the following parameters:
X, Y The collimator settings;
OFref The output factor for the reference field size;
OF (X, Y ) The measured output factor for field size X,Y;
D′(X, Y ) The reference point calculated by the algorithm for the field size X,Y and
the reference geometry, when ignoring the effect of the collimator backscatter;
D′ref The dose calculated by the algorithm for reference conditions in the reference
geometry, when ignoring the effect of the collimator backscatter.
The wedge scatter source models scatter originating from each point in a physical
wedge.
The primary beam source model describes the beam entering the patient and is
divided into finite-sized beamlets. AAA calculates dose in a divergent dose matrix
which is aligned along the coordinate system within the beam fanlines [Varian, 2015].
4.3.1 AAA Volumetric Dose Calculation
As mentioned above, AAA divides the clinical beam into finite-size beamlets, repre-
sented by the symbol β. The beamlets emerge from the focal spot of each source,
which is different for the primary, extra-focal and wedge-scattered photons.
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The dose to an arbitrary point is calculated by summing up the dose contribu-
tions from all of the individual beamlets.
A depth z is defined along the central fanline of each beamlet. AAA divides
scatter calculations into two directions: in the direction of the central fanline and
in the lateral direction [Varian, 2015].
Depth direction In the depth direction, an energy deposition density function
Iβ(z,Q) is obtained from a poly-energetic pencil beam kernel which is pre-calculated
and derived from Monte Carlo simulations. Q is the average electron density of the
voxel. Electron density in each voxel is calculated from the user-defined HU to
electron density curve.
Practically, Iβ(z,Q) is calculated by integrating over the sphere surface of the
pencil beam for the radiological depth z:
Iβ(z) =
∫ ∫
h′β(t, v, z)dtdv (4.2)
where hβ(t, v, z) is the pencil beam kernel.
To account for tissue heterogeneity in the depth direction, Iβ(z, ρ) is obtained
by
Iβ(z, ρ) = Iβ(z
′)× ρ(0, 0, z)
ρwater
, (4.3)







A one-dimensional scatter kernel kz(z) is convolved with the energy function of
the beamlet (after lateral scatter is included) in order to account for gradual changes
of scatter conditions after heterogeneity borders. To correct for the effect that this
convolution has on the depth of calculated dose, the pencil beam kernel hβ(t, v, z) in
Equation 4.2 is replaced by h′β(t, v, z), where h
′
β(t, v, z) is hβ(t, v, z) convolved with
the deconvolution kernel derived from kz(z).
Lateral direction Lateral photon scatter is modelled with a scatter kernelKβ(x, y, z).
Practically, the scatter kernel is the weighted sum of six exponential functions with
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parameters derived by fitting the functions to the Monte Carlo-derived scatter ker-
nels.
Lateral density scaling of the scatter kernel is handled by dividing the calculation
into a finite number (16) of rays diverging from the origin. The radiological scaling
used by the scatter kernels is performed independently in four lateral directions
[Sievinen et al., 2005].
The anisotropic term in the algorithm name comes from the anisotropic density
scaling of the scatter kernel in the four lateral directions. The analytic term in
the algorithm name is due to the convolution of the scatter kernel being performed
analytically.
The calculated energy deposited at each point is converted to dose by multiplying
by the ratio of water electron density and electron density at the point, and by a
scaling factor that converts between J m-3 to Gy.
4.3.2 AAA beam modelling
Eclipse has an automated optimisation procedure in which the program attempts
to fit parameters of the beam model in order to produce the best match between
measured and calculated beam profiles and PDDs. The optimiser, in general, did
a good job of producing a close fit between measured and calculated data, however
some modifications were made post-optimisation to produce a better fit. The main
parameters that were changed related to the secondary source, namely its size,
relative intensity and mean energy. These parameters had a significant effect on the
out of field dose and the shape of the outer area of the interumbra. The target spot
size of the primary source was set to 0 mm in the Y direction and 1.0 mm in the X
direction.
Figures 4.1 to 4.6 show the final agreement between measured and calculated
data for AAA. The AAA model showed some discrepancies in the maximum dose
region of the PDD (when normalised at a depth of 10 cm) for the 5 x 5 cm field. The
interumbra of larger fields showed some disagreement with measurement, with the
disagreement becoming smaller at depth. Some compromises were made to match
the penumbra of the open fields, this meant that the penumbra as calculated by
AAA in the smaller fields showed differences to measured.
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Fig. 4.1: A comparison of a 3 x 3 cm PDD (top) calculated with AAA, with 1% 1 mm
gamma comparisons (bottom). Dashed lines show the calculated PDDs, while
solid lines show the measured PDDs.
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Fig. 4.2: A comparison of a 5 x 5 cm PDD (top) calculated with AAA, with 1% 1 mm
gamma comparisons (bottom). Dashed lines show the calculated PDDs, while
solid lines show the measured PDDs.
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Fig. 4.3: A comparison of a 10 x 10 cm PDD (top) calculated with AAA, with 1% 1 mm
gamma comparisons (bottom). Dashed lines show the calculated PDDs, while
solid lines show the measured PDDs.
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Fig. 4.4: A comparison of a 40 x 40 cm PDD (top) calculated with AAA, with 1% 1 mm
gamma comparisons (bottom). Dashed lines show the calculated PDDs, while
solid lines show the measured PDDs.





















Fig. 4.5: A comparison of 3 x 3 cm (top) and 5 x 5 cm (bottom) profiles calculated with
AAA. Profiles shown are at 1.5, 5, 10, 20 and 30 cm depths. Dashed lines show
the calculated profiles, while solid lines show the measured profiles.
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Fig. 4.6: A comparison of 10 x 10 cm (top) and 40 x 40 cm (bottom) profiles calculated
with AAA. Profiles shown are at 1.5, 5, 10, 20 and 30 cm depths. Dashed lines
show the calculated profiles, while solid lines show the measured profiles.
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4.4 Acuros XB
Acuros XB solves the time-independent three-dimensional system of coupled Linear
Boltzmann Transport Equations (LBTE). The LBTE describes the macroscopic
transport of particles. For brevity, the equations solved by Acuros are not presented
in this thesis. The LBTE and the implementation of Acuros are described in detail
by Failla et al. [2010].
Acuros uses the same source model as AAA. The model consists of primary, extra
focal, electron contamination and wedge scatter. The difference is in the calculation
of dose once the primary and secondary sources are transported into the patient.
The steps taken by Acuros dose calculation are as follows:
1. Transport of source model fluence into patient
2. Calculation of scattered photon fluence in patient
3. Calculation of scattered electron fluence in patient
4. Dose calculation.
Step 1 is repeated for each beam and involves ray tracing to calculate the uncol-
lided photon and electron fluence distributions for each source [Failla et al., 2010].
Once step 1 is performed for all beams, steps 2 to 4 are performed once for the
calculation.
Because Acuros uses physical properties of materials rather than solely the den-
sity or electron density, the algorithm must know the material of each voxel. This
is achieved with a library of materials, where a lookup of mass density will give the
material. Mass density is determined from the Hounsfield Unit of the voxel.
To reduce computation time, the computational grid used for the transport of
scattered photons and electrons is of a variable size, with a higher spatial resolution
inside the beam fields and a lower spatial resolution in lower dose, lower gradient
regions outside the beam penumbra [Failla et al., 2010]. Energy discretisation is also
performed so that the Acuros XB cross section library includes 25 photon energy
groups and 49 electron energy groups [Failla et al., 2010]. The discrete ordinates
method is used to discretise in angle, which is a standard method used to discretise
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angles when solving particle transport equations. The angular discretisation varies
with particle type and energy.
Acuros XB has a cutoff kinetic energy for electrons of 500 keV and a cutoff
for photons below 1 keV. When a particle has an energy below the cutoff energy,
any subsequent interactions are assumed to happen only in that voxel [Failla et al.,
2010]. These parameters are non-adjustable but are equivalent to typical values
used in Monte Carlo techniques.
Simplifications are made to speed up calculation time, such as that pair pro-
duction is assumed to be electron + electron and not electron + positron. It is
assumed that no bremsstrahlung radiation is produced in the patient/phantom.
These two simplifications are unlikely to have a significant effect on overall calcu-
lation accuracy. Berger and Seltzer [1982] shows that the ratio of restricted stopping
powers between positrons and electrons is 1.00 (∆ = 1 keV).
The second simplification, that no bremsstrahlung radiation is produced in the
patient, has a small but insignificant effect on the dose calculation. Electrons with
energies between 0.5 - 6 MeV have bremsstrahlung fractions between 0.2% and 2%
in water [Johns and Cunningham, 1983].
Acuros and Monte Carlo approach dose calculation in similar ways: by simulating
or solving particle transport equations. They differ in cross-section data, variance
reduction techniques and approximations. Monte Carlo calculations discretise with
the number of particles in a simulation. Acuros discretises with energy, angle and
spatial resolution. As the number of particles in Monte Carlo simulations increases
and the size of the grid in Acuros decreases, the two methods will converge on the
same result.
4.4.1 Dose to water vs dose to medium
There are two quantities reported in dose calculation algorithms; dose to water
or dose to medium. Most algorithms compute and report dose to water. Many
radiotherapy treatment regimes are based on results using prescriptions of dose to
water. Beam data measurements are typically made in water and current absolute
dosimetry protocols recommend calibrating to absorbed dose in water [Andreo et al.,
2001]. Monte Carlo simulations calculate dose to medium by default. For soft tissue,
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the difference is less than 1% but it can exceed 10% in material such as corticol bone
[Siebers et al., 2000].
Acuros can calculate either dose to water or dose to medium. Once Acuros has
solved for electron angular fluence, the dose in any voxel is given by integrating over
energy and solid angles and multiplying the electron fluence by
σeED(~r,E)
ρ
, which is the
macroscopic electron energy deposition cross section, in units of MeV/cm divided
by the mass density of the material [Failla et al., 2010]. If calculating dose to water,
σeED and ρ are based on water. If calculating dose to medium, they are based on
the material properties in the voxel.
4.4.2 Acuros XB beam modelling
Similarly to AAA, the automated optimisation procedure was run using the imported
beam data in order to set the required parameters. The beam model required
significantly more tweaking that did AAA. Results are shown in Figures 4.7 to 4.12.
Disagreements between calculated and measured PDDs were similar to those for
AAA. The interumbra region of the shallower profiles calculated by Acuros showed
disagreement near the penumbra.
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Fig. 4.7: A comparison of a 3 x 3 cm PDD (top) calculated with Acuros, with 1% 1 mm
gamma comparisons (bottom). Dashed lines show the calculated PDDs, while
solid lines show the measured PDDs.
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Fig. 4.8: A comparison of a 5 x 5 cm PDD (top) calculated with Acuros, with 1% 1 mm
gamma comparisons (bottom). Dashed lines show the calculated PDDs, while
solid lines show the measured PDDs.
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Fig. 4.9: A comparison of a 10 x 10 cm PDD (top) calculated with Acuros, with 1% 1 mm
gamma comparisons (bottom). Dashed lines show the calculated PDDs, while
solid lines show the measured PDDs.
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Fig. 4.10: A comparison of a 40 x 40 cm PDD (top) calculated with Acuros, with 1% 1
mm gamma comparisons (bottom). Dashed lines show the calculated PDDs,
while solid lines show the measured PDDs.
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Fig. 4.11: A comparison of 3 x 3 cm (top) and 5 x 5 cm (bottom) profiles calculated with
Acuros. Profiles shown are at 1.5, 5, 10, 20 and 30 cm depths. Dashed lines
show the calculated profiles, while solid lines show the measured profiles.
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Fig. 4.12: A comparison of 10 x 10 cm (top) and 40 x 40 cm (bottom) profiles calculated
with Acuros. Profiles shown are at 1.5, 5, 10, 20 and 30 cm depths. Dashed
lines show the calculated profiles, while solid lines show the measured profiles.

5. ALGORITHM ACCURACY
The agreement of the Acuros and AAA models to measured beam data was presented
in Chapter 4. In this chapter, measurements and Monte Carlo calculations are used
to investigate algorithm performance in geometry of increasing complexity.
5.1 Equipment
5.1.1 Tissue-equivalent material
CIRS tissue equivalent slabs were used in this thesis. The slabs have approximately
the same material composition as common inhomogeneities such as bone, lung and
water. Slabs representing average-lung are used in this thesis. The lung slabs have
mass densities of 0.3346 g/cm3.
5.1.2 Chambers
The 31010 ionisation chamber (PTW, Freiburg, Germany) is a miniature thimble
chamber. This chamber has a measurement volume of 0.125 cm3 and a length of
6.5 mm. The PTW 31010 was used for point dose measurements. The effective
point of measurement of 1.65 mm towards the source was taken into account for all
measurements.
5.2 Algorithm accuracy in slab geometry
Measurements were made in slab geometry to assess the ability of each algorithm
to calculate dose before and after heterogeneities.
CIRS slab geometry was used in order to create the various set-ups. In each
set-up, 4 cm of water equivalent material in the form of two 2 cm slabs was placed
on top of the inhomogeneity slab. The inhomogeneity slab was followed by 15 cm
of water-equivalent material. The set-up is shown in Figures 5.1 and Figure 5.2.
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The top of the phantom was placed at 100 cm SSD and the linac gantry and
collimator were set to zero degrees. The solid water slab containing the ion chamber
slot was moved to the various slab positions to measure dose at depth. Each time
the slab was moved the alignment of the linac cross-hairs was checked against the
alignment markings on the top of the slab.
Each measurement was normalised to the ion chamber reading in slab 2 of the
inhomogeneous set-up. Calculated dose profiles were also normalised at a depth of
2.84 cm, which corresponds to the position of the effective point of measurement of
the chamber.
The measurement geometry was reproduced in the treatment planning system by
creating regions of interests based on the size of the slabs. The ROIs were manually
assigned densities. For Acuros, the ROIs were assigned to the appropriate material.
Acuros calculations were calculated with dose to water. Monte Carlo calculations
were scaled in lung and bone from dose to the medium to dose to water. This was
performed by multiplying the PDD by the average water-to-medium stopping power
ratios as calculated by Siebers et al. [2000]. For lung, the stopping power ratio was
0.999, while for bone the ratio was 1.117. Since the density of bone affects the
stopping power ratios, there is some uncertainty in using an externally calculated
stopping power ratio. It is expected that this uncertainty is less than 1% for the
dose in bone. For an 18 MV beam in cortical bone, Siebers et al. [2000] show a
variation in stopping power ratio of approximately 1% between densities of 1.5 and
2.0 g/cm3.
The slab geometry measurements show that, distal to lung, AAA overestimates
the dose relative to Acuros and Monte Carlo calculations. In the lung inhomogeneity,
AAA calculates lower dose than both Acuros and Monte Carlo. Figures 5.3 to 5.5
show examples of the slab geometry calculations for 6 cm of lung, while the rest of
the profiles are shown in Appendix A.
Figure 5.6 shows that the agreement to measurements generally improves as the
thickness of the lung slab decreases. It also shows that Monte Carlo and Acuros are
in close agreement for all configurations.
Figure 5.7 shows that, for AAA, calculations with the 3 x 3 cm field agree better
than the larger field sizes. A discussion of this particular result is presented in















Fig. 5.1: The slab geometry set-up used to assess each algorithm’s ability to predict dose
after an inhomogeneity.
Chapter 6.
In summary, Acuros, Monte Carlo and AAA have an average difference of -0.06
± 0.13%, -0.09 ± 0.12% and +0.6 ± 0.18% respectively compared to measured doses
distal to the lung slab.
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Fig. 5.2: The slab geometry set up with a 2 cm lung slab in slab 3.






























































AAA - Monte Carlo
Acuros - Monte Carlo
Fig. 5.3: Slab geometry tests with a 10 x 10 cm field involving a 6 cm slab of lung.































































AAA - Monte Carlo
Acuros - Monte Carlo
Fig. 5.4: Slab geometry tests with a 5 x 5 cm field involving a 6 cm slab of lung.






























































AAA - Monte Carlo
Acuros - Monte Carlo
Fig. 5.5: Slab geometry tests with a 3 x 3 cm field involving a 6 cm slab of lung.
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5.3 TecDoc 1583 tests
TecDoc 1583 [Vatnitsky and International Atomic Energy Agency, 2008] was used as
a guide for constructing plans on the CIRS thorax phantom to determine Acuros and
AAA accuracy in phantom geometry for various treatment fields. Point doses were
measured with the PTW TW31010 ion chamber and the PTW Unidos electrometer.
The chamber was exposed to a calibration dose of 250 cGy in solid water to determine
cGy/nC on the day of measurement. Temperature and pressure were observed
during the measurement period and found to be stable.
The eight cases are described in detail by Vatnitsky and International Atomic
Energy Agency [2008] and are summarised here:
Case 1 10 x 10 cm field at gantry and collimator zero with 100 cm source-to-phantom
distance.
Case 2 15 x 15 cm field with a 60 degree enhanced-dynamic-wedge and gantry and
collimator at 90 degrees.
Case 3 15 x 10 cm field at gantry and collimator zero, collimated by MLCs.
Case 4 Four rectangular, jaw-defined fields incident at gantry angles 0, 90, 180 and
270 degrees.
Case 5 MLC defined field incident at gantry zero, collimator zero.
Case 6 MLC defined L-shape, with gantry at 45 degrees and collimator at 90 de-
grees.
Case 7 Four fields at gantry angles 0, 90, 180 and 270 degrees, with lateral 30 degree
enhanced dynamic wedge fields.
Case 8 Two lateral rectangular fields with a non-coplanar beam at couch 270 degrees
and gantry 30 degrees.
AAA calculations agreed well with all measurement points except for one case.
The particular disagreement was with Case 2, which involved measuring at a point
distal to a beam passing through lung. AAA calculated a dose at point 1 that
was 4.2% higher than measured. This reflects a finding made by the Australian
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Clinical Dosimetric Service (ACDS) during a national audit of radiotherapy clinics.
The ACDS found that AAA calculated dose, on average, 2.9 ± 1.2% higher than
measured in regions distal from lung-tissue [Dunn et al., 2015]. The audit did not
find a significant systematic offset in any other algorithms that were tested.
Acuros calculations agreed well with all measurement points except for Case 1
point 10. This point is inside the bone inhomogeneity. All doses were calculated as
dose to water, and this discrepancy is likely due to the scaling of dose to medium
to dose to water, in order to compare to measured data.
Averaged over all cases and all measurement points, AAA calculated dose 0.4
± 0.4% higher than measured, while Acuros calculated dose 0.2 ± 0.2% lower than
measured. Detailed results are shown in Appendix A.
5.4 Algorithm verifications on CT datasets
CT images were taken using a Philips Big Bore CT and the images were exported
as DICOM files. The images were converted to a phantom through the ctcreate
program that is distributed with DOSXYZnrc. The ctcreate program takes several
inputs:
1. The format of the CT data, which was set to DICOM.
2. A text file that contains a list of all the DICOM images, one per line, in
ascending Z order.
3. The x, y, z boundaries of the phantom that is created.
4. The voxel sizes of the phantom (set to 0.2 cm for each dimension).
5. A ramp definition which converts CT number to mass density and material.
This was entered based on a scan of a CIRS electron density phantom and so
matches the CT number to mass density ramp entered into Eclipse.
The CT ramp used for Acuros and Monte Carlo calculations is shown in Fi-
gure 5.8. When Acuros determines a material, if two density ranges overlap for two
materials, Acuros will use an average material for the subsequent calculation [Va-
rian, 2015]. For the most part, the materials overlap for Acuros and Monte Carlo
calculations, however this is an additional source of uncertainty.
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Rz(θ) =





The rotation of the DOSXYZnrc coordinates is then performed by the matrix
T , where T is
T = Ry(θT )Rz(θG)Ry(π/2− θC)Rx(π/2) (5.4)
where θG is the beam gantry angle, θT is the linac table rotation angle and θC is
the linac collimator angle.
DOSXYZnrc source positions are defined using a polar coordinate system centred
on the isocentre. To obtain the polar coordinates used in DOSXYZnrc, the initial












The angles in the polar coordinate system are then










− θC − arctan
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θ, φ and φcoll are the angles defining the source position in the DOSXYZnrc
polar coordinate system and the BEAMnrc collimator angle. Verification of the
transformation matrices are shown in Appendix C.3.
For computing treatment plans in EGSnrc, the SYNCJAWS component was
used in the BEAMnrc linac definition. This component enables the user to input
jaw settings which change over the course of the simulation. The contribution from
each jaw setting is determined from the index, which ranges from 0 to 1. The index
is related to the number of monitor units for each beam. The index is cumulative so
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that the first jaw definition has an index equal to its proportion of ‘beam on’ time
and the last jaw setting has an index equal to 1.0.
Jaw opening positions of the BEAMnrc jaw component were calculated by x =
z
SAD
X, where z is the distance from the source to the jaw opening, SAD is the
source-to-axis distance of the linear accelerator, and X is the size of the jaw opening
projected down to the isocentre of the linac.
For treatment plan calculations, DOSXYZnrc source 21 was used. This source
allows a compiled BEAMnrc shared library to be used as a source from multiple
angles in a single computation. The angles, isocentre and distance from the source
are defined for each treatment beam. The muIndex(i) for each control point, which
represents the fraction of the total number of incident primary histories delivered up
to control point i, synchronises with the BEAMnrc SYNCJAWS component [Walters
et al., 2005]. A computer program was written in order to convert treatment plans
in the DICOM format to the required input files for Monte Carlo calculations.
Similarly to the slab geometry tests above, Monte Carlo calculated dose was
scaled from dose to medium to dose to water by multiplying the dose in each voxel
by the stopping power ratio (medium to water) of the material in the image in the
same voxel.
5.4.1 CIRS thorax dataset calculations
A 3 cm diameter PTV was drawn in the left lung in Eclipse. A program was written
to convert the Eclipse regions of interests (ROIs) into a DICOM image dataset, which
could then be used as input for a Monte Carlo calculation A plan was calculated
with AAA, Acuros and DOSXYZnrc involving a right-left 4 x 4 cm field and an
anterior-posterior 4 x 4 cm field, with their isocentres at the centre of the PTV.
Profiles and dose-volume-histograms were calculated with DicomViewer (Appen-
dix C.2). The Acuros profile is in better agreement with the Monte Carlo profile
through the central slice of the PTV (Figures 5.9 and 5.10). In both the left lung
and the PTV, Acuros dose-volume-histograms were closer to the Monte Carlo dose-
volume-histograms than AAA (Figures 5.11 and 5.12).
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5.4.2 Patient dataset calculations
SBRT lung patients were chosen for calculations due to the prevalence of reasonably
small fields and due to the presence of low density material, which has typically
been a difficult scenario for dose calculation.
Previous clinical plans were chosen and patient CT datasets converted to an
.EGSPHANTOM file. MLCs were removed in the plan, since the MLCs were not
commissioned for the Monte Carlo model created for this study. The plan was
exported and input into DOSXYZnrc in the appropriate format, using the BEAMnrc
component SYNCJAWS. Monte Carlo calculations were compared to AAA, Acuros
and CCC for three plans. Gamma analysis was performed with the software SNC
Patient (Sun Nuclear, Melbourne FL). The gamma analysis was performed with a
threshold of 20%. The effect of the 20% threshold, as implemented in SNC Patient,
is to remove dose points from the analysis when they are less than 20% of the
normalisation dose, except for points inside a complex or bifurcated field. All dose
distributions were normalised to the maximum dose.
The CT datasets used in this section are shown in Figure 5.13.
Plan 1
Plan 1 was a 12 field SBRT lung plan with multiple non-coplanar beams. A com-
parison for an axial plane through the PTV was made (Figures 5.14 - 5.16). The
gamma agreements to Monte Carlo (2%, 2 mm) for Acuros, AAA and CCC were
100.0%, 98.8% and 99.5% respectively. Both AAA and CCC underestimated the
dose in a section of the PTV relative to Monte Carlo. CCC appears to underesti-
mate the dose in the PTV. Calculations with heterogeneity corrections turned off
agree well between Acuros, AAA and CCC (100% gamma pass rate with the criteria
2%, 2 mm). This suggests that any disagreements between the algorithms are due
to the algorithm implementation and radiation transport in low density mediums.
Plan 2
Plan 2 was a 10 field SBRT plan with multiple non-coplanar beams. A comparison
for an axial plane through the PTV was made (Figures 5.17 - 5.19). The gamma
agreements to Monte Carlo (2%, 2 mm) for Acuros, AAA and CCC were 98.3%,
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(a) Plan 1 CT Dataset and normalised dose distribu-
tion.
(b) Plan 2 CT Dataset and normalised dose distribu-
tion.
(c) Plan 3 CT Dataset and normalised dose distribu-
tion.
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97.8% and 98.1% respectively. In this case the air dose was not zeroed in Monte
Carlo calculations. This resulted in some disagreements outside of the body contour.
Agreement in the PTV was good in all cases. As the dose was not zeroed outside
the body contour in the Monte Carlo calculations, the gamma pass rate of CCC is
somewhat misleading, as CCC has excellent agreement with Monte Carlo inside the
body.
Plan 3
Plan 3 was a 10 field SBRT plan with multiple non-coplanar beams. A comparison
for an axial plane through the PTV was made (Figures 5.20 - 5.22). The gamma
agreements to Monte Carlo (2%, 2 mm) for Acuros, AAA and CCC were 95.8%,
96.8% and 92.5% respectively. As in plan 2, the air dose was not zeroed in Monte
Carlo calculations, resulting in some disagreements outside of the body contour.
Agreement in the PTV was good for all algorithms.
The average gamma pass rates (2%, 2 mm) in the three plans for Acuros, AAA







6. DISCUSSION AND CONCLUSION
6.1 Discussion
This thesis has examined the accuracy of the LBTE solver Acuros XB. When com-
pared to measurements or dose distributions calculated by Monte Carlo, dose cal-
culated using Acuros agreed more closer than that calculated using AAA in most
cases.
In slab geometry tests, Acuros agrees much more closely to Monte Carlo dose
calculations than AAA. As the thickness of the inhomogeneity decreases, each al-
gorithm agrees more closely with the measured dose. This is in agreement with
the literature and is an intuitive result. A counter-intuitive result is that as the
field size decreases from 10 x 10 cm2 to 3 x 3 cm2, AAA calculations agree better
with measured dose. Smaller fields in low density regions exhibit a loss of electronic
equilibrium and so it is expected that they would be more difficult to model for
most dose calculation algorithms. A possible explanation for this effect is that it is
a result of two opposite errors in the dose calculation. In all cases, AAA overesti-
mates the rebuild-up of dose in the region distal to lung. In the 3 x 3 cm2 field,
the algorithm is likely overestimating the loss of dose due to electronic equilibrium
more significantly than at the other field sizes. Because of this underestimation of
dose before the lung-water interface in the small field, the effect of the overestima-
tion of the rebuild-up is reduced and the resulting dose is closer to measured than
what would be expected. Further work, outside the scope of this thesis, could be
undertaken to investigate this discrepancy.
The consistent overestimation of dose calculated by AAA distal to lung inhomo-
geneities could potentially result in lower tumour control probabilities for treatment
sites distal to lung. The systematic offset is shown in this report by the TecDoc
1583 tests, with AAA calculating higher doses distal to lung in Case 2. This finding
is mirrored by a national audit performed by the ACDS [Dunn et al., 2015]. The
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offset is also found in the slab inhomogeneity tests in this report. Dunn et al. [2015]
speculates that the reason for the offset is that “AAA uses Gaussian functions to
describe the mean heterogeneous effect in four lateral directions, instead of over 4π,
as implemented in Acuros XB.”
In calculations on CT datasets, Acuros had a higher average gamma pass rate
than CCC and AAA when compared to the Monte Carlo calculation. This agrees
with both Han et al. [2013], who compared the AAA and Acuros to film measure-
ments in a thorax phantom, and Fogliata et al. [2011a], who compared AAA and
Acuros to Monte Carlo in virtual phantoms using 2D gamma comparisons. In order
to provide a statistically significant result, future work could involve calculations
using a larger number of clinical plans. Future work could also include the use of
MLCs in static or IMRT/VMAT fields.
There are some limitations in this study with respect to the comparison of the
three dose calculation algorithms. Since this thesis compares three algorithms with
three different beam models, it is difficult to differentiate when an algorithm has a
better beam model or when it calculates radiation transport more accurately. To
remedy this somewhat, many calculations were performed in simple slab geometry,
for field sizes that agree well in water phantom calculations.
Another limitation is the effect of dose normalisation in Monte Carlo calculated
dose. As there is some statistical variation in dose from voxel to voxel due to the
finite number of particles simulated, dose normalisation to a single point may result
in a large difference in isodoses and DVHs. Large numbers of histories were used in
the Monte Carlo calculations to remove some of this uncertainty.
A final uncertainty in the dose comparisons made in this study is the conversion
of dose from dose to the medium to dose to water. In the case of Monte Carlo, the
dose in each voxel is scaled by an amount based on the material in that voxel. The
number of materials is limited to four: air, lung, tissue and bone. While this likely
encapsulates the majority of the materials present in a CT scan of a patient, the HU
thresholds between these materials may not match those that Acuros uses. Stopping
power ratios to water calculated by Siebers et al. [2000] are used in this thesis. These
values are relatively depth-independent on the central beam axis but may differ in
shielded regions where there is a larger proportion of low-energy scattered radiation.
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6.2 Conclusion
Acuros XB has been shown to calculate dose in different geometries with comparable
accuracy to Monte Carlo calculations. In the majority of cases presented here,
Acuros dose distributions match Monte Carlo dose distributions more closely than
AAA, however the difference is mostly small. In almost all cases where the algorithm
computes radiation dose in or distal to lung, Acuros computes dose which matches






EXTENDED SLAB GEOMETRY RESULTS






























































AAA - Monte Carlo
Acuros - Monte Carlo































































AAA - Monte Carlo
Acuros - Monte Carlo
Fig. A.2: Slab geometry tests with a 5 x 5 cm field involving a 2 cm slab of lung.






























































AAA - Monte Carlo
Acuros - Monte Carlo































































AAA - Monte Carlo
Acuros - Monte Carlo
Fig. A.4: Slab geometry tests with a 10 x 10 cm field involving a 3 cm slab of lung.






























































AAA - Monte Carlo
Acuros - Monte Carlo
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Fig. A.6: Slab geometry tests with a 3 x 3 cm field involving a 3 cm slab of lung.
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Fig. A.8: Slab geometry tests with a 5 x 5 cm field involving a 4 cm slab of lung.
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Fig. A.9: Slab geometry tests with a 3 x 3 cm field involving a 4 cm slab of lung.
Appendix B
TABLES FROM TECDOC 1583 TESTS
Below are the results from the verification tests based on TecDoc 1583. Note that, as
per TecDoc 1583, the difference presented for each measurement point is normalised
to the reference point in the plan.
B.1 AAA
Point Expected (cGy) Reading (nC) Measured (cGy) Difference (%) Criteria(%)
1 241.2 7.802 242.26 -0.53 2
3 199 6.438 199.91 -0.46 2
5 169.7 5.501 170.82 -0.56 2
9 17.7 0.475 14.75 1.48 4
10 123.1 3.965 123.12 -0.01 3
Tab. B.1: AAA calculations vs point dose measurements in TecDoc 1583 Case 1.
Point Expected (cGy) Reading (nC) Measured (cGy) Difference (%) Criteria(%)
1 169.3 5.232 162.47 4.21 2
Tab. B.2: AAA calculations vs point dose measurements in TecDoc 1583 Case 2.
Point Expected (cGy) Reading (nC) Measured (cGy) Difference (%) Criteria
3 198.9 6.442 200.04 -0.57 2
Tab. B.3: AAA calculations vs point dose measurements in TecDoc 1583 Case 3.
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Point Expected (cGy) Reading (nC) Measured (cGy) Difference (%) Criteria(%)
5 F1 50.2 1.609 49.96 0.12 2
5 F2 49.7 1.617 50.21 -0.26 3
5 F3 50 1.557 48.35 0.84 3
5 F4 50 1.552 48.19 0.92 3
5 Sum 199.5 6.335 196.71 1.42
6 F1 4.1 0.102 3.17 0.47 4
6 F2 5.6 0.1295 4.02 0.80 3
6 F3 30.2 1.027 31.89 -0.86 3
6 F4 64.8 2.117 65.74 -0.48 4
6 Sum 104.3 3.3755 104.82 -0.26
10 F1 36.1 1.157 35.93 0.09 3
10 F2 70.6 2.325 72.20 -0.81 4
10 F3 3.6 0.114 3.54 0.03 4
10 F4 3.6 0.1125 3.49 0.05 3
10 Sum 113.9 3.7085 115.16 -0.64
Tab. B.4: AAA calculations vs point dose measurements in TecDoc 1583 Case 4.
Point Expected (cGy) Reading (nC) Measured (cGy) Difference (%) Criteria (%)
2 198.7 6.393 198.52 0.09 2
7 165 5.457 169.45 -2.24 4
Tab. B.5: AAA calculations vs point dose measurements in TecDoc 1583 Case 5.
Point Expected (cGy) Reading (nC) Measured (cGy) Difference (%) Criteria (%)
3 199.3 6.331 196.59 1.38 3
7 101.7 3.464 107.56 -2.98 4
10 11.3 0.382 11.86 -0.29 5
Tab. B.6: AAA calculations vs point dose measurements in TecDoc 1583 Case 6.
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Point Expected (cGy) Reading (nC) Measured (cGy) Difference (%) Criteria (%)
5 (0) 66 2.105 65.36 0.34 2
5 (90) 61.7 1.956 60.74 0.51 4
5 (270) 61.5 1.959 60.83 0.36 4
5 (Sum) 189.2 6.02 186.93 1.21
Tab. B.7: AAA calculations vs point dose measurements in TecDoc 1583 Case 7.
Point Expected (cGy) Reading (nC) Measured (cGy) Difference (%) Criteria (%)
5 (90) 65.4 2.047 63.56 0.95 3
5 (270) 65.3 2.052 63.72 0.82 3
5 (30) 66 2.131 66.17 -0.09 3
5 (Sum) 196.7 6.23 193.45 1.68
Tab. B.8: AAA calculations vs point dose measurements in TecDoc 1583 Case 8.
B.2 Acuros
Point Expected (cGy) Reading (nC) Measured (cGy) Difference (%) Criteria (%)
1 240.5 7.802 242.27 -0.88 2
3 198.3 6.438 199.91 -0.81 2
5 168.6 5.501 170.82 -1.11 2
9 16 0.475 14.75 0.63 4
10 131.8 3.965 123.12 4.34 3
Tab. B.9: Acuros calculations vs point dose measurements in TecDoc 1583 Case 1.
Point Expected (cGy) Reading (nC) Measured (cGy) Difference (%) Criteria (%)
1 162.40 5.23 162.46 -0.04 2
Tab. B.10: Acuros calculations vs point dose measurements in TecDoc 1583 Case 2.
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Point Expected (cGy) Reading (nC) Measured (cGy) Difference (%) Criteria (%)
3 198.2 6.442 200.04 -0.92 2
Tab. B.11: Acuros calculations vs point dose measurements in TecDoc 1583 Case 3.
Point Expected (cGy) Reading (nC) Measured (cGy) Difference (%) Criteria (%)
5 F1 49.6 1.609 49.96 -0.18 2
5 F2 49.7 1.617 50.21 -0.26 3
5 F3 47.9 1.557 48.35 -0.23 3
5 F4 47.8 1.552 48.19 -0.20 3
5 Sum 195 6.335 196.71 -0.87
6 F1 3.3 0.102 3.17 0.07 4
6 F2 4.2 0.1295 4.02 0.09 3
6 F3 32 1.027 31.89 0.06 3
6 F4 65.9 2.117 65.74 0.08 4
6 Sum 105.4 3.3755 104.82 0.30
10 F1 38.6 1.157 35.93 1.36 3
10 F2 76.3 2.325 72.20 2.09 4
10 F3 3.7 0.114 3.54 0.08 4
10 F4 3.7 0.1125 3.49 0.11 3
10 Sum 122.3 3.7085 115.16 3.63
Tab. B.12: Acuros calculations vs point dose measurements in TecDoc 1583 Case 4.
Point Expected (cGy) Reading (nC) Measured (cGy) Difference (%) Criteria (%)
2 198.3 6.393 198.52 -0.11 2
7 166.6 5.457 169.45 -1.44 4
Tab. B.13: Acuros calculations vs point dose measurements in TecDoc 1583 Case 5.
B.2. Acuros 113
Point Expected (cGy) Reading (nC) Measured (cGy) Difference (%) Criteria (%)
3 198.9 6.331 196.59 1.17 3
7 106.7 3.464 107.56 -0.44 4
10 13.1 0.382 11.86 0.63 5
Tab. B.14: Acuros calculations vs point dose measurements in TecDoc 1583 Case 6.
Point Expected (cGy) Reading (nC) Measured (cGy) Difference (%) Criteria (%)
5 (0) 65.6 2.105 65.36 0.13 2
5 (90) 59.5 1.956 60.74 -0.66 4
5 (270) 59.3 1.959 60.83 -0.82 4
5 (Sum) 184.4 6.02 186.93 -1.36
Tab. B.15: Acuros calculations vs point dose measurements in TecDoc 1583 Case 7.
Point Expected (cGy) Reading (nC) Measured (cGy) Difference (%) Criteria (%)
5 (90) 63.4 2.047 63.56 -0.08 3
5 (270) 63.3 2.052 63.72 -0.22 3
5 (30) 66 2.131 66.17 -0.09 3
5 (Sum) 192.2 6.23 193.45 -0.65
Tab. B.16: Acuros calculations vs point dose measurements in TecDoc 1583 Case 8.

Appendix C
TOOLS FOR DOSE DISTRIBUTION COMPARISONS
C.1 Gamma
Low et al. [1998] introduced the γ value in 1998, and it is now a commonly used
parameter for the comparison of two dose distributions. The γ value (gamma)
incorporates both dose and spatial difference information into one calculation, Hence
γ is useful in both high and low dose-gradient regions.
If ~rm is a point in the measured dose distribution and ~rc is a point in the cal-
culated dose distribution, then a value of γ is obtained for each point ~rm in the
measured dose distribution.
For each ~rm, γ is defined as
γ( ~rm) = min
~rc
Γ( ~rm, ~rc), (C.1)
with
Γ( ~rm, ~rc) =
√












where ∆d2M and ∆D
2
M are spatial and dose difference tolerances.
For comparing measured profiles and PDDs with those calculated by DOSXY-
Znrc, a program was written which performs a one dimensional gamma analysis on
the two curves. The dose difference and distance tolerances used were 1% and 1 mm
respectively.










Fig. C.1: Geometric representation of the γ value γ(~rc, ~rm) for ~rm in the measured distri-
bution and one point in the calculated distribution ~rc.
C.2 DicomViewer
For dose comparisons, it is useful to assess differences by looking at isodose lines
drawn on a CT dataset or by looking at the difference in the calculation’s Dose
Volume Histograms (DVH). Most modern TPS have the ability to draw isodose lines
and calculate DVH from a treatment plan. Comparing DOSXYZnrc calculated doses
to doses calculated in TPS is difficult as the output of DOSXYZnrc calculations
are in the .3ddose format. The format is described by [Walters et al., 2005] and
essentially lists the x, y and z voxel locations and the relative dose in each voxel.
Non-commercial tools available for reading and writing .3ddose files are limited and
so a program (called DicomViewer) was written for this study in order to properly
compare EGSnrc doses to those from the TPS.
C.2.1 DICOM RT
The DICOM standard enables a standardised method of communicating diagnostic
and therapeutic images and information. In radiation therapy, for example, the
DICOM standard provides a way to transfer CT images, treatment plans, ROI con-
tours and dose information from one software system to another. In DicomViewer,
dose distribution, CT images and regions of interests are read from DICOM files.
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The free and open source Fellow Oak DICOM library is used to read data from
DICOM files.
Isodose lines
Isodose lines were drawn onto CT images through the Marching Squares algorithm
Lorensen and Cline [1987]. The dose grid is sampled at a customisable grid spacing
and given to the marching squares algorithm for dose drawing.
Dose volume histograms
A DVH is a convenient way to represent dose distribution through a region of in-
terest. A differential DVH shows, for many dose intervals, the volume of a region
of interest that has a dose in that interval. A cumulative DVH displays the volume
of the region of interest that has a dose greater than or equal to a certain dose.
DicomViewer calculates differential DVH via the following algorithm:
1. Find the dimensions of the cube surrounding the entire volume of the region
of interest
2. Divide the cube into voxels of dimensions smaller than the size of the dose
grid
3. For each voxel, determine whether the centre of the voxel is inside the region
of interest. This is determined by first converting the slice on each polygon
into a binary mask. If the centre of the voxel is not on the same slice as a
polygon then a polygon is created from the interpolation of the surrounding
slices, as described by Schenk et al. [2000]
4. If the centre of the voxel is inside the region of interest, interpolate the dose
at the centre of the voxel and add the voxel volume to the relevant dose bin
(Figure C.2).
Comparisons to Eclipse DVH calculation Multiple cumulative DVH curves cal-
culated in Eclipse were compared to those calculated in DicomViewer. Complete
agreement is not expected due to the difference in algorithm implementation, howe-
ver good agreement was found for the calculations performed (Figure C.3).
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C.3 DICOM to DOSXYZnrc geometry coordinate transformation
verification
Calculations with different beam parameters were made with Eclipse and DOSXY-
Znrc to verify the transformations from DICOM coordinates to DOSXYZnrc dis-
cussed in Section 5.4. The results are presented below.
C.3.1 Geometry verification test 1
X1 (cm) X2 (cm) Y1 (cm) Y2 (cm) iso (cm) θG θT θC θ φ φcoll
5 -2 8 0 (0, 0, 0) 0 0 0 90 270 270
Tab. C.1: Eclipse beam parameters and DOSXYZnrc cylindrical coordinates for verifica-
tion test 1.
(a) Eclipse dose (Axial) (b) DOSXYZnrc dose (Axial)
(c) Eclipse dose (Coronal) (d) DOSXYZnrc dose (Coronal)
Fig. C.4: Dose distributions from geometry verification test 1.
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C.3.2 Geometry verification test 2
X1 (cm) X2 (cm) Y1 (cm) Y2 (cm) iso (cm) θG θT θC θ φ φcoll
5 -2 8 0 (0, 0, 0) 0 60 0 90 270 210
Tab. C.2: Eclipse beam parameters and DOSXYZnrc cylindrical coordinates for verifica-
tion test 2.
(a) Eclipse dose (Axial) (b) DOSXYZnrc dose (Axial)
(c) Eclipse dose (Coronal) (d) DOSXYZnrc dose (Coronal)
Fig. C.5: Dose distributions from geometry verification test 2.
C.3. DICOM to DOSXYZnrc geometry coordinate transformation verification 121
C.3.3 Geometry verification test 3
X1 (cm) X2 (cm) Y1 (cm) Y2 (cm) iso (cm) θG θT θC θ φ φcoll
5 -2 8 0 (0, 0, 0) 320 60 0 247.24 217 100
Tab. C.3: Eclipse beam parameters and DOSXYZnrc cylindrical coordinates for verifica-
tion test 3.
(a) Eclipse dose (Axial) (b) DOSXYZnrc dose (Axial)
(c) Eclipse dose (Coronal) (d) DOSXYZnrc dose (Coronal)
Fig. C.6: Dose distributions from geometry verification test 3.
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C.3.4 Geometry verification test 4
X1 (cm) X2 (cm) Y1 (cm) Y2 (cm) iso (cm) θG θT θC θ φ φcoll
-2 -5 -2 8 (0, 0, 0) 15 270 45 105 270 315
Tab. C.4: Eclipse beam parameters and DOSXYZnrc cylindrical coordinates for verifica-
tion test 4.
(a) Eclipse dose (Axial) (b) DOSXYZnrc dose (Axial)
(c) Eclipse dose (Coronal) (d) DOSXYZnrc dose (Coronal)
Fig. C.7: Dose distributions from geometry verification test 4.
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C.3.5 Geometry verification test 5
X1 (cm) X2 (cm) Y1 (cm) Y2 (cm) iso (cm) θG θT θC θ φ φcoll
-2 -5 -2 8 (-5,5,-3) 15 270 45 105 270 315
Tab. C.5: Eclipse beam parameters and DOSXYZnrc cylindrical coordinates for verifica-
tion test 5.
(a) Eclipse dose (Axial) (b) DOSXYZnrc dose (Axial)
(c) Eclipse dose (Coronal) (d) DOSXYZnrc dose (Coronal)
Fig. C.8: Dose distributions from geometry verification test 5.
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C.4 Uncertainties
In this study, when a result has been presented as a ± b, b represents 1.96 × σ−x ,
where σ−x is the standard error of the mean x̄ and is equal to σ/
√
(n), where σ is
the standard deviation of the set of results and n is the number of samples.
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